Ian Watson Lab
@IanWatsonLab
Followers
482
Following
535
Media
12
Statuses
214
Canada Research Chair II/Associate Professor Goodman Cancer Inst., Dept Biochemistry, McGill University/Investigator RI-MUHC/CCTG Melanoma Disease Site Co-chair
Montréal, Québec
Joined June 2018
RT @jwoodgett: Clinical trials have been repeatedly shown to result not only in better future outcomes (including removal of failed interve….
0
3
0
RT @CDNCancerTrials: The Canadian Cancer Trials Group (#CCTG) is joining forces with @marathonofhope (#MOHCCN) to conduct three pan-Canadia….
0
14
0
RT @MDankner: Check out our latest preprint on MAPK-targeted therapies for patients with MAP2K1/MEK1 mutant cancers. Hopefully helpful for….
medrxiv.org
PURPOSE MAP2K1/MEK1 mutations are potentially actionable drivers in cancer. MAP2K1 mutations have been functionally classified into three groups according to their dependency on upstream RAS/RAF...
0
8
0
RT @gingraslab1: This is a really cool study by Elena Kuzmin (@ElenaK35) and Morag Park, two fantastic colleagues in Montreal. Our (*now gr….
0
4
0
RT @ProfRScolyerMIA: Absolutely thrilled & humbled to touch down in #Philadelphia to discover @ProfGLongMIA & I selected as joint nominee f….
0
69
0
RT @ShainLab: I want to highlight a preprint from my colleagues, Boris Bastian and Dirk Hockemeyer, that unravels the mystery of the dyspla….
biorxiv.org
TERT promoter mutations (TPMs) are frequently found in different cancer types, including approximately 70% of sun-exposed skin melanomas. In melanoma, TPMs are among the earliest mutations and can be...
0
5
0
RT @LupoCiyuCy: Excited to share our work “Insulin Receptor Loss Impairs Mammary Tumorigenesis in Mice“. Led by @LaurenMPodmore and @KatPlz….
cell.com
Insulin receptor (INSR) is found in most human breast cancers. Podmore et al. demonstrate that INSR contributes to cancer development in two mouse models representing major human breast cancer types...
0
28
0
RT @SonenbergLab: His impact and legacy will forever inspire us. We will be honouring Dr. Jerry Pelletier's incredible legacy through vario….
0
9
0
RT @McGillMed: We are saddened to share the news that iconic McGill professor Jerry Pelletier has passed away. Our condolences to his famil….
0
15
0
RT @SonenbergLab: It is with heavy hearts that we share the passing of Dr. Jerry Pelletier, an esteemed alumnus of the Sonenberg lab and a….
0
30
0
RT @tfri_research: Adrian Thorogood is our Data Governance Manager. He met up with researchers from @IanWatsonLab at the run in Montreal! h….
0
2
0
RT @KaylaHeney1: Had a great #TerryFoxRun2023 in Montreal with the @IanWatsonLab and the members of the @McGillGCI ! What a lovely event to….
0
3
0
RT @marathonofhope: 🚨 New funding announcement! 🚨. We're delighted to announce the winners of our inaugural MOHCCN Health Informatics & Dat….
0
13
0
RT @marathonofhope: “This study puts Canada at the forefront of microbiome research by showing we can safely improve patients’ response to….
0
4
0
RT @jwoodgett: Claire’s talk was a highlight of this years Banff signalling meeting. Learn about adaptation of BioID for measuring signalli….
0
5
0
RT @doctorveera: A mind-blowing paper has come out today in @Nature . In 2016, JC Venter Institute scientists trimmed a bacterial genome t….
0
6K
0
RT @NatureMedicine: In patients with advanced #melanoma, fecal microbiota transplantation from healthy donors combined with anti-PD-1 #immu….
nature.com
Nature Medicine - In patients with advanced melanoma, fecal microbiota transplantation from healthy donors combined with the anti-PD-1 inhibitors nivolumab or pembrolizumab was well tolerated with...
0
19
0
RT @McGillGCI: Seven GCI scientists ranked top 100 in Canada for their disciplines: @SonenbergLab, Gros, Pelletier, @MoragPark1, Giguère, T….
0
6
0
RT @SMImmunology: In 2016, I came up with a plan to change cancer patients' gut microbiome before immunotherapy. Now we have multiple trial….
nature.com
Nature Medicine - In patients with advanced melanoma, fecal microbiota transplantation from healthy donors combined with the anti-PD-1 inhibitors nivolumab or pembrolizumab was well tolerated with...
0
29
0
RT @McGillGCI: Press Release: New study published in @NatureComms identifies amino acid to potentially treat aggressive cancers. https://t.….
0
4
0